Search Main Menu Main Content
  • Change contrast :
Retour à l'accueil du site de la HAS
logo HAS
icone
  • HAS profile
    • Mission
    • Organisational Structure
    • Ethics, transparency and management of conflicts of interest
  • International relations and projects
  • Publications
  1. Recherche
  • icone plus

  • My account

    • Email alert Subscription
    • Newsletter Subscription
    • My search
    Refresh
    Please fill in your email address to retrieve your email alerts subscriptions.
    New subscription
    Please fill in your email address to retrieve your newsletter subscriptions.

    You do not have a saved search

    Mon Compte

  • No element in selection

    Favoris
  • Établissements de santé
  • Contact Contact

2 results

  • Active substance : trinitrine
Filter
Topic
  • Diseases and conditions (2)
  • Plus ...
    • Heart diseases (1)
    • Plus ...
      • Myocardial ischemia (1)
    • Pregnancy and reproduction (1)
    • Plus ...
      • Contraception, abortion and sterilization (1)
  • Diagnostic and therapeutic techniques (1)
  • Plus ...
    • Diagnostic techniques and procedures (1)
    • Plus ...
      • Medical imaging (1)
Content type
  • Drugs, devices and medical acts (1)
  • Plus ...
    • Health technology assessment (1)
  • Practice Guidelines and Other Guides (1)
  • Plus ...
    • Practice guidelines (1)
Language
  • Français (2)
Active substance
  • aminophylline (1)
  • ceftriaxone (1)
  • dinoprostone (1)
  • dipyridamole (1)
  • doxycycline (1)
  • fentanyl (1)
  • fer (1)
  • gadolinium (1)
  • halothane (1)
  • isoflurane (1)
  • midazolam (1)
  • misoprostol (1)
  • morphine (1)
  • propofol (1)
  • sufentanil (1)
  • sulprostone (1)
  • trinitrine (2)

Practice guidelines and other guides - 1 result

  • Induced abortion up to 14 weeks

    Practice guidelines - Posted on 1/3/2001 - Mis à jour le 19/7/2006
    Add to my selection

Drugs, devices and medical acts - 1 result

  • Evaluation of non-invasive cardiac imaging in diagnosis of chronic coronary artery disease - INAHTA Brief

    Health technology assessment - Posted on 2/12/2016
    Download document
    Add to my selection
Haute Autorité de Santé
Advancing quality in the fields of health and social care services

Follow us :

  • Twitter (nouvelle fenêtre)
  • Facebook (nouvelle fenêtre)
  • Youtube (nouvelle fenêtre)
  • LinkedIn (nouvelle fenêtre)
  • Eunetha.eu
  • Pasq.eu
  • All our publications by topic and type
  • Opinions on medicines
  • Opinions on medical devices
  • INAHTA briefs
  • fr Français
  • en English
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
kKA8Br9c6ztwdGeq